Domov › Debelost › Indiana › Indianapolis
Klinične študije za Debelost v Indianapolis, IN
20 študij za Debelost išče udeležence na lokacijah v Indianapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Vključevanje udeležencevFaza 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Vključevanje udeležencevFaza 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Vključevanje udeležencevFaza 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Vključevanje udeležencevFaza 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Vključevanje udeležencevFaza 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Vključevanje udeležencevFaza 3
- Indiana University Health University Hospital, Indianapolis
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Vključevanje udeležencevFaza 3
- Midwest Inst For Clin Res, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Vključevanje udeležencevFaza 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Vključevanje udeležencevFaza 3
- AURORA-2 Clinical Site, Indianapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- Ascension Medical Group, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Vključevanje udeležencevFaza 2
- Investigators Research Group, Brownsburg · 14 mi stran
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Vključevanje udeležencevFaza 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi stran
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Vključevanje udeležencevFaza 3
- Midwest Inst For Clin Res, Indianapolis
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Vključevanje udeležencevFaza 2
- Indiana University School of Medicine, Indianapolis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Indiana University Health Methodist Hospital, Indianapolis
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Indiana University Hospital, Indianapolis
Fibrosis Lessens After Metabolic Surgery
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
- Indiana University, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Vključevanje udeležencev
- Indiana University, Indianapolis
Študije za Debelost v drugih mestih
- Houston, TX43 študij
- Chicago, IL41 študij
- New York City, NY40 študij
- San Antonio, TX40 študij
- Washington, DC33 študij
- Orlando, FL31 študij
- Dallas, TX30 študij
- Boston, MA28 študij
- Las Vegas, NV27 študij
- Miami, FL27 študij
- Baltimore, MD25 študij
- Jacksonville, FL25 študij
Druge študije v Indianapolis
- Nemalicelični pljučni rak32 študij
- Rak (vse vrste)24 študij
- Srčno popuščanje23 študij
- Rak dojke20 študij
- Metastatski rak19 študij
- Kolorektalni rak18 študij
- Rak jajčnikov17 študij
- Rak pljuč16 študij
- Srčno-žilne bolezni16 študij
- Sladkorna bolezen tipa 114 študij
- Rak endometrija14 študij
- Alzheimerjeva bolezen14 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.